Neuroscience-led research for the future of recovery.
RESET investigates the biology of the addiction loop — the circuits, signalling, and behavioural patterns that keep recovery out of reach. Our work is grounded in the broader scientific landscape, and developed under conditions appropriate for authorized clinical research.
The loop
Addiction is sustained by self-reinforcing circuits in the brain that respond to reward, stress, and learned cues. Existing treatments rarely address this biology at its source.
The opportunity
A new generation of investigational compounds may, in controlled clinical research, help re-open windows of neuroplasticity — periods during which the brain can re-learn patterns it has otherwise locked in.
The discipline
Promise alone is not science. What turns a hypothesis into a credible programme is rigorous research design, GMP-aligned development, and conservative claims throughout.
Evidence-respecting, claim-careful.
How RESET approaches the science — four positions that govern every programme decision.
Evidence-respecting
We reference the broader landscape of controlled research to explain the category. We do not represent third-party study results as our own.
Mechanism-curious, claim-careful
We describe how compounds are being studied — never what they do for a person.
Physician-supervised by design
All RESET research happens within authorized clinical research settings, under physician supervision.
Open about uncertainty
Recovery science is not finished. Honest risk disclosure is part of the work.
The scientific landscape referenced is broader than RESET's own programmes. Mechanism descriptions are general and educational; they do not represent RESET study results or regulatory determinations.
Build the regulated future of addiction recovery with us.
Science. Compassion. Transformation. RESET is a clinical-stage neurotherapeutics company — partner with the discipline behind a new era of recovery research.